Back to Search
MARTHA LACY, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1881668366Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
34878(MN)
Research & Publications (20)
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group.
PMID 19243818·Leuk Res·2009
3-trial
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
PMID 18656793·J Heart Lung Transplant·2008
8-other
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
PMID 18804043·Biol Blood Marrow Transplant·2008
4-observational
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma.
PMID 18474873·J Clin Oncol·2008
3-trial
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
PMID 17908524·Mayo Clin Proc·2007
8-other
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
PMID 16901028·Mayo Clin Proc·2006
6-review
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
PMID 16230566·Arch Dermatol·2005
8-other
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins.
PMID 19427507·Mutat Res·2009
7-preclinical
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
PMID 19181644·Mayo Clin Proc·2009
3-trial
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
PMID 19330657·Leuk Lymphoma·2009
8-other
Nosocomial transmission of invasive group a streptococcus from patient to health care worker.
PMID 19580415·Clin Infect Dis·2009
5-case
Neurocognitive outcome after endoscopic third ventriculocisterostomy in patients with obstructive hydrocephalus.
PMID 19402925·J Int Neuropsychol Soc·2009
8-other
Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT.
PMID 18850016·Bone Marrow Transplant·2009
5-case
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
PMID 18997825·Bone Marrow Transplant·2009
4-observational
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
PMID 19211640·Haematologica·2009
8-other
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
PMID 19324902·Blood·2009
8-other
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
PMID 19403931·Nephrol Dial Transplant·2009
8-other
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
PMID 18385667·Kidney Int·2008
8-other
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
PMID 18332915·Bone Marrow Transplant·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1881668366
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile